its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

Treatment to reduce asthma-related morbidity requires that asthma severity be classified based on frequency of symptoms and history of exacerbation ... evidence-based guidelines are developed.

BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe exacerbations .

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in ...

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

USA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term ...